Table 2. Baseline characteristics by testosterone level.
| Low TL | High TL | Total | P-value | |
|---|---|---|---|---|
| No. of patients |
49 |
52 |
101 |
|
|
Age (years) | ||||
| Median (IQR) | 71.0 (64.0, 75.0) | 69.0 (64.0, 75.0) | 70.0 (64.0, 75.0) | 0.5862 |
| Min, Max |
52.0, 85.0 |
41.0, 89.0 |
41.0, 89.0 |
|
|
Visceral metastases, n (%) | ||||
| Yes | 11 (22.5) | 13 (25.0) | 24 (23.8) | 0.7634 |
| No | 38 (77.6) | 39 (75.0) | 79 (78.2) | |
| Missing data |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
|
Hepatic metastases, n (%) | ||||
| Yes | 6 (12.2) | 6 (11.5) | 12 (11.9) | 0.9127 |
| No | 43 (87.8) | 46 (88.5) | 89 (88.1) | |
| Missing data |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
|
Gleason score | ||||
| ⩽7 | 18 (36.7) | 21 (40.4) | 39 (38.6) | 1.0000 |
| >7 | 25 (51.0) | 28 (53.9) | 53 (52.5) | |
| Missing data |
6 (12.2) |
3 (5.8) |
9 (8.9) |
|
|
Haemoglobin value (g l−1) | ||||
| Median (IQR) | 132.0 (120.0, 138.0) | 130.5 (123.0, 138.0) | 131.0 (122.0, 138.0) | 0.5397 |
| Min, Max |
98.0, 156.0 |
93.0, 153.0 |
93.0, 156.0 |
|
|
Alkaline phosphatase (IU l−1) | ||||
| Median (IQR) | 179.0 (120.0, 291.0) | 129.0 (77.0, 245.5) | 163.0 (87.0, 260.0) | 0.0531 |
| Min, Max |
58.0, 1159.0 |
39.0, 790.0 |
39.0, 1159.0 |
|
|
PSA (ng ml−1) | ||||
| Median (IQR) | 59.5 (19.5, 202.0) | 50.2 (17.6, 124.5) | 50.7 (18.9, 138.0) | 0.3138 |
| Min, Max |
2.4, 1284.0 |
0.04, 514.0 |
0.04, 1284.0 |
|
|
LDH | ||||
| Normal | 27 (55.1) | 34 (65.4) | 61 (60.4) | 0.6254 |
| High | 12 (24.5) | 11 (21.2) | 23 (22.8) | |
| Missing data | 10 (20.4) | 7 (13.5) | 17 (16.8) | |
Abbreviations: IQR=interquartile range; LDH=lactate dehydrogenase; PSA, prostate-specific antigen, TL=testosterone level.
Data are number of patients (%) or median (IQR).